Disparity Between Blood Pressure and PRA Inhibition After Administration of a Renin Inhibitor to Anesthetized Dogs: Methodological Considerations

References

• Hofbauer K. G., Wood J. M. Renin inhibitors as possible antihypertensive agents. Klin Wochenschrift 1988; 66: 906–913
   PubMedGoogle Scholar
• Corvol P., Chauveau D., Jeunemaitre X., Menard J. Human renin inhibitor peptides. Hypertension 1990; 16: 1–11
   PubMed Web of Science ®Google Scholar
• Blaine E. H., Schorn T. W., Boger J. Statine-containing renin inhibitor: Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs. Hypertension 1984; 6: 1111–1118
   Google Scholar
• Kleinert H. D., Martin D., Chekal M. A., Kadam J., Luly J. R., Plattner J. J., Perun T. J., Luther R. R. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity. Hypertension 1988; 11: 613–619
   PubMed Web of Science ®Google Scholar
• Wood J. M., Criscione L., de Gasparo M., Buhlmayer P., Rueger H., Stanton J. L., Jupp R. A., Kay J. CGP 38 560: Orally active, low molecular-weight renin inhibitor with high potency and specificity. J Cardiovasc Pharmacol 1989; 14: 221–226
   PubMed Web of Science ®Google Scholar
• Dzau V. J. Vascular angiotensin pathways: A new therapeutic target. J Cardiovasc Pharmacol 1987; 10(Suppl 7)S9–S16
   PubMedGoogle Scholar
• Campbell D. J. Extra renal renin and blood pressure regulation. Am J Hypertension 1989; 2: 266–275
   PubMed Web of Science ®Google Scholar
• Poulsen K., Jorgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissue based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1973; 39: 816–825
   Web of Science ®Google Scholar
• Barrett J., Eggena P., Sambhi M. P. Influence of angiotensinase inhibitors on the enzymatic activity of renin. Biochemical Medicine 1976; 16: 157–168
   PubMed Web of Science ®Google Scholar
• Preibisz J. J., Sealey J. E., Aceto R. M., Laragh J. H. Plasma renin activity measurements: An update. Cardiovascular Reviews and Reports 1982; 3: 787–804
   Google Scholar
• Jeunemaitre X., Menard J., Nussberger J., Guyene T. T., Brunner H. R., Corvol P. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560 A in hypertensive patients. Am J Hypertens 1989; 2: 819–827
   PubMed Web of Science ®Google Scholar
• Repine J. T., Himmelsbach R. J., Hodges J. C., Kaltenbronn J. S., Sircar I., Skeean R. W., Brennan S. T., Hurley T. R., Lunney E., Humblet C. C., Weishaar R. E., Rapundalo S., Ryan M. J., Taylor D. G., Olson S. C., Michniewicz B. M., Kornberg B. E., Belmont D. T., Taylor M. D. Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of metyl aminomalonate. J Med Chem 1991; 34: 1935–1943
   PubMed Web of Science ®Google Scholar
• Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol 1969; 29: 1349–1355
   PubMed Web of Science ®Google Scholar
• Nussberger J., d'Amore T. F., Porchet M., Waeber B., Brunner D. B., Brunner H. R., Kler L., Brown A. N., Francis R. J. Repeated administration of the converting enzyme inhibitor Cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987; 9: 39–44
   PubMed Web of Science ®Google Scholar
• Nussberger J., Brunner D. B., Waeber B., Brunner H. R. True versus immunoreactive angiotensin II in human plasma. Hypertension 1985; 7(Suppl 1)11–117
   Google Scholar
• Verburg K. M., Kleinert H. D., Kadam J. R.C., Chekal M. A., Mento P. F., Wilkes B. M. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys. Hypertension 1989; 13: 262–72
   PubMed Web of Science ®Google Scholar
• Cordero P., Fisher N., Moore T. J., Gleason R., Williams G. H., Hollenberg N. K. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Hypertension 1991; 17: 510–516
   PubMed Web of Science ®Google Scholar
• Neuberg G. W., Kukin M. L., Penn J., et al. Does circulating renin reflect the activity of the renin-angiotensin system in heart failure?. Circulation 1989; 80(Suppl II)629
   Google Scholar
• Bursztyn M., Gavras I., Tifft C. P., Luther R., Boger R., Gavras H. Effects of a novel renin inhibitor in patients with essential hypertension. J Cardiovasc Pharmacol 1990; 15: 493–500
   PubMed Web of Science ®Google Scholar
• Van der Meiraker A. H., Admiraal P. J. J., Man in't Veld A. J., Derkx F. H. M., Ritsema van Eck H. J., Mulder P., van Brummelen P., Shalekamp M. A. D.H. Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension. Brit Med J 1990; 301: 205–210
   PubMed Web of Science ®Google Scholar
• Wood J. M., Baum H. P., Jobber R. A., Nesius D. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets. J Cardiovasc Pharmacol 1987; 10(Suppl 7)S96–S98
   PubMedGoogle Scholar
• Sealy J. E., Laragh J. H. How to do a plasma renin assay. Cardiovasc Med 1977; 2: 1079–1092
   Google Scholar
• Greenlee W. J. Renin inhibitors. Pharmaceutical Research 1987; 4: 364–374
   PubMed Web of Science ®Google Scholar
• Derkx F. H. M., van den Meiracker A. H., Fischli W., Admiraal P. J. J., Man in't Veld A. J., van Brummelen P., Shalekamp M. A. D.H. Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensin I and II in hypertensive subjects: An assay-related artifact. Am J Hypertension 1991; 4: 602–609
   PubMed Web of Science ®Google Scholar
• Higuchi K., Higashimori K., Natarajan S., Spitzmiller E. R., Inagami T. Lowering of hypertension by a novel renin inhibitor, SO 34017, in spontaneously hypertensive rats. J Hypertension 1990; 8(Suppl 3)S42
   Google Scholar